Clinical Trials Browser

NIH × Autoimmune Diseases × Clear all

NCT03816345 2026-03-18

Nivolumab in Treating Patients With Autoimmune Disorders and Advanced, Metastatic, or Unresectable Cancer

Phase 1 Recruiting

Other hematologic neoplasm

Arthritis, Rheumatoid, Autoimmune Diseases, Colitis, Ulcerative, Crohn Disease, Dermatomyositis, Lupus Erythematosus, Systemic, Multiple Sclerosis, Psoriasis, Scleroderma, Systemic, Sjogren's Syndrome, Inflammatory Bowel Diseases, Arthritis, Psoriatic, Hematologic Neoplasms

NCT00867269 2026-03-09

Etiology, Pathogenesis, and Natural History of Idiopathic CD4+ Lymphocytopenia

Classical hematology

Autoimmune Diseases, Immunologic Deficiency Syndromes, Opportunistic Infections, Warts, Meningitis, Cryptococcal, T-Lymphocytopenia, Idiopathic CD4-Positive

NCT03922724 2025-12-31

Allogeneic Hematopoietic Cell Transplantation for Peripheral T Cell Lymphoma

Phase 2 Recruiting

Autoimmune Diseases, Immune System Diseases, Lymphoproliferative Disorders, Opportunistic Infections, Lymphoma, T-Cell, Peripheral

NCT00001582 2023-03-21

Investigation of the Human Immune Response in Normal Subjects and Patients With Disorders of the Immune System and Cancer

LymphoidPlasma cell

Autoimmune Diseases, Lymphoma, B-Cell, Lymphoma, T-Cell, Neoplasms, Plasma Cell

NCT00340600 2020-11-16

Continuation of Follow-up of DES-Exposed Cohorts

10,805 enrolled

BreastGenitourinaryGynecologic

Autoimmune Diseases, Breast Neoplasms, Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Endometrial Neoplasms

NCT00466843 2009-06-02

Effects of Antithymocyte Globulin in Adults With Myelodysplastic Syndrome

Phase 2 Unknown

MyeloidOther hematologic neoplasm

Autoimmune Diseases, Leukemia, Myelodysplastic Syndromes